Literature DB >> 3049687

Biology of hypopigmentation.

J L Bolognia1, J M Pawelek.   

Abstract

A review of the basics of pigment cell biology is followed by a discussion of the characteristics of several disorders of hypopigmentation. By determining such features as inheritance pattern, time of onset (congenital, childhood, adulthood), natural history (stable vs progressive), type of pigment loss (diffuse or circumscribed), distribution of lesions (generalized vs localized), degree of pigment loss (incomplete or complete), number of melanocytes, if any, in biopsy specimens of affected areas, type of melanocytic dysfunction, and associated inflammation or infection, one can classify the disorders of hypopigmentation. The proposed pathophysiology for each disorder of hypomelanosis is presented.

Entities:  

Mesh:

Year:  1988        PMID: 3049687     DOI: 10.1016/s0190-9622(88)70168-1

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  7 in total

Review 1.  Hypopigmentary skin disorders: current treatment options and future directions.

Authors:  Anke Hartmann; Eva-B Bröcker; Jürgen C Becker
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Nevoid malignant melanoma in an albino woman.

Authors:  F Binesh; A Akhavan; H Navabii
Journal:  BMJ Case Rep       Date:  2010-12-06

3.  Sebocytes contribute to melasma onset.

Authors:  Enrica Flori; Arianna Mastrofrancesco; Sarah Mosca; Monica Ottaviani; Stefania Briganti; Giorgia Cardinali; Angela Filoni; Norma Cameli; Marco Zaccarini; Christos C Zouboulis; Mauro Picardo
Journal:  iScience       Date:  2022-02-04

4.  From melanocyte to metastatic malignant melanoma.

Authors:  Bizhan Bandarchi; Linglei Ma; Roya Navab; Arun Seth; Golnar Rasty
Journal:  Dermatol Res Pract       Date:  2010-08-11

5.  Co-occurrence of progressive hemifacial atrophy due to morphea with homolateral segmental vitiligo: A case report.

Authors:  Pukar Chapagain; Sudha Agrawal
Journal:  Clin Case Rep       Date:  2021-07-21

Review 6.  Quality of life in patients with vitiligo.

Authors:  Davinder Parsad; Sunil Dogra; Amrinder Jit Kanwar
Journal:  Health Qual Life Outcomes       Date:  2003-10-23       Impact factor: 3.186

7.  Plasma & urinary catecholamines & urinary vanillylmandelic acid levels in patients with generalized vitiligo.

Authors:  Binamra Basnet; Aditya Bhushan; Rehan Khan; Guresh Kumar; Vinod Kumar Sharma; Alpana Sharma; Somesh Gupta
Journal:  Indian J Med Res       Date:  2018-04       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.